Clinical Trial

Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life

Recruiting
View on ClinicalTrials.gov →
Summary
This randomized controlled trial aims to evaluate the effect of nurse-led telehealth monitoring on medication adherence, self-efficacy, and quality of life in individuals with inflammatory bowel disease (IBD). The study will be conducted at the IBD Outpatient Clinic of Istanbul University-Cerrahpaşa, Cerrahpaşa Medical Faculty. Participants will be randomly assigned to either an intervention group receiving a 3-month structured telehealth program (including education, counseling, phone calls, and reminders) or a control group receiving only standard care and an educational booklet. Outcomes will be assessed at baseline and after 12 weeks.
Trial Details
NCT Number NCT06971627
Lead Sponsor Istanbul University - Cerrahpasa
Conditions Inflammatory Bowel Disease (IBD), Medication Compliance, Quality of Life, Telehealth Monitoring
Enrollment 120 participants
Start Date 2024-04-20
Primary Completion 2024-07-20 (estimated)
Study Completion 2025-05-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-14